Actinogen Medical Limited, a biotechnology company, develops therapies for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol in Australia. It develops Xanamem, an oral medication and inhibitor of the 11ß-HSD1 enzyme that achieves target engagement in the brain for the treatment of Alzheimer's disease, major depressive disorder, fragile x syndrome, and other neurological diseases. The company was formerly known as Actinogen Limited and changed its name to Acti...
Industry: Biotechnology
Sector: Healthcare
Phone: 61 2 8964 7401
Fax: 61 2 8964 7588
Address:
109 Pitt Street, Suite 901, Level 9, Sydney, Australia
